{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T22:55:33Z","timestamp":1776380133958,"version":"3.51.2"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T00:00:00Z","timestamp":1746921600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T00:00:00Z","timestamp":1746921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32470568"],"award-info":[{"award-number":["32470568"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Key Research and Development (R&D) Program of China","award":["2022YFF0710503"],"award-info":[{"award-number":["2022YFF0710503"]}]},{"name":"Jilin Provincial Science and Technology Development Plan Project","award":["20230505037ZP"],"award-info":[{"award-number":["20230505037ZP"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Skin cutaneous melanoma (SKCM) arises from melanocytes and is an aggressive form of skin cancer. If left untreated, most melanomas will metastasize, posing a major health risk. GADD45B, a member of the GADD45 family, is known to be involved in DNA damage repair; however, its specific role in SKCM remains largely unclear. In this study, we comprehensively investigated the function of GADD45B in SKCM. By integrating 26 SKCM-related datasets from The Cancer Genome Atlas (TCGA), Cancer Cell Line Encyclopedia (CCLE), cBioPortal for Cancer Genomics (cBioPortal), Gene Expression Omnibus (GEO), and other databases, we conducted functional enrichment, immune infiltration, and single-cell analyses using R. Additionally, transcriptome sequencing of 30 human SKCM cell lines, phenotype characterization of 29 SKCM lines in vitro, and macrophage polarization analysis were performed. We found that GADD45B expression was significantly downregulated in SKCM patients compared to normal controls (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), and higher GADD45B levels correlated with better prognosis (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). GADD45B also showed high diagnostic accuracy, with an area under the curve (AUC) of 0.986. GO and KEGG analyses revealed a strong association between GADD45B and immune-related pathways. Gene Set Variation Analysis (GSVA) and single-cell sequencing suggested that GADD45B may serve as a novel immune checkpoint, predominantly expressed in macrophages and promoting M1 polarization. In vitro, overexpression of GADD45B significantly inhibited SKCM cell proliferation, potentially via suppression of the PI3K\/Akt signaling pathway, and also reduced chemotherapy resistance. Furthermore, in vivo experiments using a xenograft mouse model demonstrated that GADD45B overexpression significantly suppressed tumor growth. Mice injected with GADD45B-overexpressing tumor cells exhibited smaller tumor volumes from day 15 onwards compared to controls, with markedly reduced tumor volume and weight at the endpoint. These results underscore the potential of GADD45B as an effective tumor suppressor in SKCM. In conclusion, our findings highlight GADD45B as a key regulator in SKCM progression, capable of restraining tumor cell proliferation and enhancing apoptosis. GADD45B holds promise as a novel diagnostic and prognostic biomarker and a potential target for SKCM immunotherapy.<\/jats:p>","DOI":"10.1186\/s41065-025-00437-0","type":"journal-article","created":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T16:11:42Z","timestamp":1746979902000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Integrated bioinformatic analysis identifies GADD45B as an immune-related prognostic biomarker in skin cutaneous melanoma"],"prefix":"10.1186","volume":"162","author":[{"given":"Qing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhonghao","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruirui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yimin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,11]]},"reference":[{"key":"437_CR1","doi-asserted-by":"crossref","unstructured":"Strashilov S, Yordanov A. Aetiology and pathogenesis of cutaneous melanoma: current concepts and advances. Int J Mol Sci, 2021. 22(12).","DOI":"10.3390\/ijms22126395"},{"issue":"3","key":"437_CR2","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/CMR.0000000000000235","volume":"26","author":"L Chiriboga","year":"2016","unstructured":"Chiriboga L, et al. Endothelin-1 in the tumor microenvironment correlates with melanoma invasion. Melanoma Res. 2016;26(3):236\u201344.","journal-title":"Melanoma Res"},{"issue":"5","key":"437_CR3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","volume":"158","author":"M Arnold","year":"2022","unstructured":"Arnold M, et al. Global burden of cutaneous melanoma in 2020 and projections to 2040. JAMA Dermatol. 2022;158(5):495\u2013503.","journal-title":"JAMA Dermatol"},{"key":"437_CR4","doi-asserted-by":"crossref","unstructured":"Goodson AG, Grossman D. Strategies for early melanoma detection: approaches to the patient with nevi. J Am Acad Dermatol, 2009. 60(5): p. 719\u2013\u200935; quiz 736-8.","DOI":"10.1016\/j.jaad.2008.10.065"},{"issue":"11","key":"437_CR5","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41568-020-0285-7","volume":"20","author":"D Bruni","year":"2020","unstructured":"Bruni D, Angell HK, Galon J. The immune contexture and immunoscore in cancer prognosis and therapeutic efficacy. Nat Rev Cancer. 2020;20(11):662\u201380.","journal-title":"Nat Rev Cancer"},{"key":"437_CR6","doi-asserted-by":"crossref","unstructured":"Teixido C et al. Molecular markers and targets in melanoma. Cells, 2021. 10(9).","DOI":"10.3390\/cells10092320"},{"issue":"10","key":"437_CR7","doi-asserted-by":"publisher","first-page":"e1468956","DOI":"10.1080\/2162402X.2018.1468956","volume":"7","author":"DL Bajor","year":"2018","unstructured":"Bajor DL, et al. Long-term outcomes of a phase I study of agonist CD40 antibody and CTLA-4 Blockade in patients with metastatic melanoma. Oncoimmunology. 2018;7(10):e1468956.","journal-title":"Oncoimmunology"},{"issue":"3","key":"437_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/jjco\/hyv201","volume":"46","author":"S Suzuki","year":"2016","unstructured":"Suzuki S, et al. Current status of immunotherapy. Jpn J Clin Oncol. 2016;46(3):191\u2013203.","journal-title":"Jpn J Clin Oncol"},{"issue":"1\u20132","key":"437_CR9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1615\/CritRevOncog.v16.i1-2.120","volume":"16","author":"DA Liebermann","year":"2011","unstructured":"Liebermann DA, et al. Gadd45 stress sensors in malignancy and leukemia. Crit Rev Oncog. 2011;16(1\u20132):129\u201340.","journal-title":"Crit Rev Oncog"},{"issue":"11","key":"437_CR10","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.1002\/eji.200839154","volume":"39","author":"S Ju","year":"2009","unstructured":"Ju S, et al. Gadd45b and Gadd45g are important for anti-tumor immune responses. Eur J Immunol. 2009;39(11):3010\u20138.","journal-title":"Eur J Immunol"},{"issue":"25","key":"437_CR11","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1038\/sj.onc.1202574","volume":"17","author":"DA Liebermann","year":"1998","unstructured":"Liebermann DA, Hoffman B. MyD genes in negative growth control. Oncogene. 1998;17(25):3319\u201329.","journal-title":"Oncogene"},{"issue":"4","key":"437_CR12","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/sj.leu.2402477","volume":"16","author":"DA Liebermann","year":"2002","unstructured":"Liebermann DA, Hoffman B. Myeloid differentiation (MyD)\/growth arrest DNA damage (GADD) genes in tumor suppression, immunity and inflammation. Leukemia. 2002;16(4):527\u201341.","journal-title":"Leukemia"},{"issue":"22","key":"437_CR13","doi-asserted-by":"publisher","first-page":"9309","DOI":"10.1158\/0008-5472.CAN-10-1033","volume":"70","author":"DL Ou","year":"2010","unstructured":"Ou DL, et al. Induction of DNA damage-inducible gene GADD45beta contributes to sorafenib-induced apoptosis in hepatocellular carcinoma cells. Cancer Res. 2010;70(22):9309\u201318.","journal-title":"Cancer Res"},{"key":"437_CR14","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/1479-5876-10-215","volume":"10","author":"L Wang","year":"2012","unstructured":"Wang L, et al. Abnormal expression of GADD45B in human colorectal carcinoma. J Transl Med. 2012;10:215.","journal-title":"J Transl Med"},{"issue":"10","key":"437_CR15","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1210\/en.2011-0109","volume":"152","author":"KA Michaelis","year":"2011","unstructured":"Michaelis KA, et al. Identification of growth arrest and DNA-damage-inducible gene beta (GADD45beta) as a novel tumor suppressor in pituitary gonadotrope tumors. Endocrinology. 2011;152(10):3603\u201313.","journal-title":"Endocrinology"},{"key":"437_CR16","doi-asserted-by":"publisher","first-page":"1021207","DOI":"10.3389\/fnmol.2022.1021207","volume":"15","author":"XY Shen","year":"2022","unstructured":"Shen XY, et al. The role of Gadd45b in neurologic and neuropsychiatric disorders: an overview. Front Mol Neurosci. 2022;15:1021207.","journal-title":"Front Mol Neurosci"},{"key":"437_CR17","doi-asserted-by":"publisher","unstructured":"Schmitz I. Gadd45 Proteins in Immunity 2.0. Adv Exp Med Biol. 2022;1360:69\u201386. https:\/\/doi.org\/10.1007\/978-3-030-94804-7_5. PMID: 35505163.","DOI":"10.1007\/978-3-030-94804-7_5"},{"key":"437_CR18","doi-asserted-by":"crossref","unstructured":"Tirosh, I., et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science. 2016;352(6282):189\u201396.","DOI":"10.1126\/science.aad0501"},{"key":"437_CR19","doi-asserted-by":"crossref","unstructured":"Salerno, D. M., et al., Gadd45a and Gadd45b modulate innate immune functions of granulocytes and macrophages by differential regulation of p38 and JNK signaling. J Cell Physiol. 2012;227(11):3613\u201320.","DOI":"10.1002\/jcp.24067"},{"issue":"11","key":"437_CR20","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1002\/jcp.24067","volume":"227","author":"DM Salerno","year":"2012","unstructured":"Liu, L., et al. Gadd45 beta and Gadd45 gamma are critical for regulating autoimmunity. J Exp Med. 2005;202(10):1341\u201347","journal-title":"J Cell Physiol"},{"issue":"10","key":"437_CR21","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1084\/jem.20051359","volume":"202","author":"L Liu","year":"2005","unstructured":"Inowa, T., et al. GADD45\u03b2 determines chemoresistance and invasive growth of side population cells of human embryonic carcinoma. Stem Cells Int. 2010;2010:782967.","journal-title":"J Exp Med"},{"issue":"1","key":"437_CR22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12935-023-02962-2","volume":"23","author":"S He","year":"2023","unstructured":"He S, et al. HOPX is a tumor-suppressive biomarker that corresponds to T cell infiltration in skin cutaneous melanoma. Cancer Cell Int. 2023;23(1):122.","journal-title":"Cancer Cell Int"},{"key":"437_CR23","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.3389\/fimmu.2019.01756","volume":"10","author":"ZL Wang","year":"2019","unstructured":"Wang ZL, et al. Immune cytolytic activity is associated with genetic and clinical properties of glioma. Front Immunol. 2019;10:1756.","journal-title":"Front Immunol"},{"key":"437_CR24","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12935-020-01271-2","volume":"20","author":"B Huang","year":"2020","unstructured":"Huang B, et al. Identification of immune-related biomarkers associated with tumorigenesis and prognosis in cutaneous melanoma patients. Cancer Cell Int. 2020;20:195.","journal-title":"Cancer Cell Int"},{"key":"437_CR25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.drup.2019.04.001","volume":"43","author":"E Hays","year":"2019","unstructured":"Hays E, Bonavida B. YY1 regulates cancer cell immune resistance by modulating PD-L1 expression. Drug Resist Updat. 2019;43:10\u201328.","journal-title":"Drug Resist Updat"},{"issue":"2","key":"437_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.canlet.2014.03.013","volume":"347","author":"Q Wu","year":"2014","unstructured":"Wu Q, et al. Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches. Cancer Lett. 2014;347(2):159\u201366.","journal-title":"Cancer Lett"},{"issue":"1","key":"437_CR27","doi-asserted-by":"publisher","first-page":"17445","DOI":"10.1038\/s41598-023-44777-1","volume":"13","author":"S He","year":"2023","unstructured":"He S, et al. Investigation of LGALS2 expression in the TCGA database reveals its clinical relevance in breast cancer immunotherapy and drug resistance. Sci Rep. 2023;13(1):17445.","journal-title":"Sci Rep"},{"issue":"10400","key":"437_CR28","first-page":"485","volume":"402","author":"GV Long","year":"2023","unstructured":"Long GV, et al. Cutan Melanoma Lancet. 2023;402(10400):485\u2013502.","journal-title":"Cutan Melanoma Lancet"},{"issue":"1","key":"437_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, et al. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"437_CR30","doi-asserted-by":"crossref","unstructured":"Untiveros G et al. Normal skin cells increase aggressiveness of cutaneous melanoma by promoting Epithelial-to-Mesenchymal transition via nodal and Wnt activity. Int J Mol Sci, 2021. 22(21).","DOI":"10.3390\/ijms222111719"},{"issue":"3","key":"437_CR31","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.ejso.2016.11.001","volume":"43","author":"K Lasithiotakis","year":"2017","unstructured":"Lasithiotakis K, Zoras O. Metastasectomy in cutaneous melanoma. Eur J Surg Oncol. 2017;43(3):572\u201380.","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"437_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12672-022-00477-2","volume":"13","author":"J Ma","year":"2022","unstructured":"Ma J, et al. Pan-cancer analysis of necroptosis-related gene signature for the identification of prognosis and immune significance. Discov Oncol. 2022;13(1):17.","journal-title":"Discov Oncol"},{"key":"437_CR33","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2147\/OTT.S281450","volume":"14","author":"L Gong","year":"2021","unstructured":"Gong L, et al. GADD45B facilitates metastasis of ovarian Cancer through Epithelial-Mesenchymal transition. Onco Targets Ther. 2021;14:255\u201369.","journal-title":"Onco Targets Ther"},{"issue":"5","key":"437_CR34","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/pros.23469","volume":"78","author":"H Huang","year":"2018","unstructured":"Huang H, et al. Matrine inhibits the progression of prostate cancer by promoting expression of GADD45B. Prostate. 2018;78(5):327\u201335.","journal-title":"Prostate"},{"issue":"8","key":"437_CR35","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s41419-020-02859-2","volume":"11","author":"S Han","year":"2020","unstructured":"Han S, et al. Sulforaphene inhibits esophageal cancer progression via suppressing SCD and CDH3 expression, and activating the GADD45B-MAP2K3-p38-p53 feedback loop. Cell Death Dis. 2020;11(8):713.","journal-title":"Cell Death Dis"},{"issue":"1","key":"437_CR36","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40659-019-0244-5","volume":"52","author":"H Do","year":"2019","unstructured":"Do H, et al. TFAP2C increases cell proliferation by downregulating GADD45B and PMAIP1 in non-small cell lung cancer cells. Biol Res. 2019;52(1):35.","journal-title":"Biol Res"},{"key":"437_CR37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/978-1-4614-8289-5_4","volume":"793","author":"I Schmitz","year":"2013","unstructured":"Schmitz I. Gadd45 proteins in immunity. Adv Exp Med Biol. 2013;793:51\u201368.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"437_CR38","doi-asserted-by":"publisher","first-page":"1747340","DOI":"10.1080\/2162402X.2020.1747340","volume":"9","author":"AR Dancsok","year":"2020","unstructured":"Dancsok AR, et al. Tumor-associated macrophages and macrophage-related immune checkpoint expression in sarcomas. Oncoimmunology. 2020;9(1):1747340.","journal-title":"Oncoimmunology"},{"issue":"2","key":"437_CR39","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1158\/1078-0432.CCR-19-1868","volume":"26","author":"IG House","year":"2020","unstructured":"House IG, et al. Macrophage-Derived CXCL9 and CXCL10 are required for antitumor immune responses following immune checkpoint Blockade. Clin Cancer Res. 2020;26(2):487\u2013504.","journal-title":"Clin Cancer Res"},{"key":"437_CR40","doi-asserted-by":"publisher","first-page":"765615","DOI":"10.3389\/fimmu.2021.765615","volume":"12","author":"Q Zhao","year":"2021","unstructured":"Zhao Q, et al. Pattern recognition receptors (PRRs) in macrophages possess prognosis and immunotherapy potential for melanoma. Front Immunol. 2021;12:765615.","journal-title":"Front Immunol"},{"issue":"1","key":"437_CR41","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jcmgh.2021.01.020","volume":"12","author":"G Li","year":"2021","unstructured":"Li G, et al. Identification of novel Population-Specific cell subsets in Chinese ulcerative colitis patients using Single-Cell RNA sequencing. Cell Mol Gastroenterol Hepatol. 2021;12(1):99\u2013117.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"7697","key":"437_CR42","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nature25980","volume":"555","author":"S Zhong","year":"2018","unstructured":"Zhong S, et al. A single-cell RNA-seq survey of the developmental landscape of the human prefrontal cortex. Nature. 2018;555(7697):524\u20138.","journal-title":"Nature"},{"issue":"6","key":"437_CR43","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.stem.2017.03.007","volume":"20","author":"L Li","year":"2017","unstructured":"Li L, et al. Single-Cell RNA-Seq analysis maps development of human germline cells and gonadal niche interactions. Cell Stem Cell. 2017;20(6):858\u2013e8734.","journal-title":"Cell Stem Cell"},{"issue":"6","key":"437_CR44","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1089\/scd.2010.0372","volume":"20","author":"TC Chang","year":"2011","unstructured":"Chang TC, et al. Derivation and characterization of novel nonhuman primate embryonic stem cell lines from in vitro-fertilized baboon preimplantation embryos. Stem Cells Dev. 2011;20(6):1053\u201362.","journal-title":"Stem Cells Dev"},{"issue":"6","key":"437_CR45","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/s41556-018-0105-4","volume":"20","author":"S Gao","year":"2018","unstructured":"Gao S, et al. Tracing the temporal-spatial transcriptome landscapes of the human fetal digestive tract using single-cell RNA-sequencing. Nat Cell Biol. 2018;20(6):721\u201334.","journal-title":"Nat Cell Biol"},{"issue":"6","key":"437_CR46","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.brs.2015.07.036","volume":"8","author":"H Jun","year":"2015","unstructured":"Jun H, et al. Gadd45b mediates electroconvulsive shock induced proliferation of hippocampal neural stem cells. Brain Stimul. 2015;8(6):1021\u20134.","journal-title":"Brain Stimul"},{"issue":"3","key":"437_CR47","doi-asserted-by":"publisher","first-page":"353","DOI":"10.7150\/ijbs.9813","volume":"11","author":"B Liu","year":"2015","unstructured":"Liu B, et al. Gadd45b is a novel mediator of neuronal apoptosis in ischemic stroke. Int J Biol Sci. 2015;11(3):353\u201360.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"437_CR48","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/stmcls\/sxab001","volume":"40","author":"L Zhang","year":"2022","unstructured":"Zhang L, et al. Gadd45g, A novel antidepressant target, mediates Metformin-Induced neuronal differentiation of neural stem cells via DNA demethylation. Stem Cells. 2022;40(1):59\u201373.","journal-title":"Stem Cells"},{"key":"437_CR49","doi-asserted-by":"crossref","unstructured":"Wu X et al. Interleukin 17D enhances the developmental competence of cloned pig embryos by inhibiting apoptosis and promoting embryonic genome activation. Anim (Basel), 2021. 11(11).","DOI":"10.3390\/ani11113062"},{"issue":"1","key":"437_CR50","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12958-019-0499-2","volume":"17","author":"F Guo","year":"2019","unstructured":"Guo F, et al. Menstrual blood derived mesenchymal stem cells combined with Bushen Tiaochong recipe improved chemotherapy-induced premature ovarian failure in mice by inhibiting GADD45b expression in the cell cycle pathway. Reprod Biol Endocrinol. 2019;17(1):56.","journal-title":"Reprod Biol Endocrinol"},{"key":"437_CR51","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.3389\/fphys.2020.01074","volume":"11","author":"M Xue","year":"2020","unstructured":"Xue M, et al. GADD45B promotes Glucose-Induced renal tubular Epithelial-Mesenchymal transition and apoptosis via the p38 MAPK and JNK signaling pathways. Front Physiol. 2020;11:1074.","journal-title":"Front Physiol"},{"issue":"13\u201314","key":"437_CR52","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1101\/gad.325696.119","volume":"33","author":"KM Sch\u00fcle","year":"2019","unstructured":"Sch\u00fcle KM, et al. GADD45 promotes locus-specific DNA demethylation and 2\u00a0C cycling in embryonic stem cells. Genes Dev. 2019;33(13\u201314):782\u201398.","journal-title":"Genes Dev"},{"key":"437_CR53","doi-asserted-by":"crossref","unstructured":"Lad\u00e1nyi A et al. Identification of a tumor cell associated type I IFN resistance gene expression signature of human melanoma, the components of which have a predictive potential for immunotherapy. Int J Mol Sci, 2022. 23(5).","DOI":"10.3390\/ijms23052704"},{"issue":"6122","key":"437_CR54","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1126\/science.1229259","volume":"339","author":"FW Huang","year":"2013","unstructured":"Huang FW, et al. Highly recurrent TERT promoter mutations in human melanoma. Science. 2013;339(6122):957\u20139.","journal-title":"Science"},{"issue":"1","key":"437_CR55","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1038\/s41467-021-22953-z","volume":"12","author":"T Budden","year":"2021","unstructured":"Budden T, et al. Ultraviolet light-induced collagen degradation inhibits melanoma invasion. Nat Commun. 2021;12(1):2742.","journal-title":"Nat Commun"},{"issue":"2","key":"437_CR56","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.molcel.2018.06.023","volume":"71","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, et al. Macrophage-Associated PGK1 phosphorylation promotes aerobic Glycolysis and tumorigenesis. Mol Cell. 2018;71(2):201\u2013e2157.","journal-title":"Mol Cell"},{"issue":"3","key":"437_CR57","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1073\/pnas.1614035114","volume":"114","author":"P Chen","year":"2017","unstructured":"Chen P, et al. Gpr132 sensing of lactate mediates tumor-macrophage interplay to promote breast cancer metastasis. Proc Natl Acad Sci U S A. 2017;114(3):580\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"437_CR58","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.7150\/thno.29617","volume":"9","author":"P Jiang","year":"2019","unstructured":"Jiang P, et al. CD137 promotes bone metastasis of breast cancer by enhancing the migration and osteoclast differentiation of monocytes\/macrophages. Theranostics. 2019;9(10):2950\u201366.","journal-title":"Theranostics"},{"issue":"10","key":"437_CR59","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1016\/j.cmet.2021.09.002","volume":"33","author":"SM Morrissey","year":"2021","unstructured":"Morrissey SM, et al. Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming. Cell Metab. 2021;33(10):2040.\u20132058.e10.","journal-title":"Cell Metab"},{"issue":"4","key":"437_CR60","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani SA, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133(4):704\u201315.","journal-title":"Cell"},{"issue":"11","key":"437_CR61","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/ncb3041","volume":"16","author":"H Lu","year":"2014","unstructured":"Lu H, et al. A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages. Nat Cell Biol. 2014;16(11):1105\u201317.","journal-title":"Nat Cell Biol"},{"key":"437_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actbio.2019.02.012","volume":"88","author":"J Kim","year":"2019","unstructured":"Kim J, Manspeaker MP, Thomas SN. Augmenting the synergies of chemotherapy and immunotherapy through drug delivery. Acta Biomater. 2019;88:1\u201314.","journal-title":"Acta Biomater"},{"issue":"1","key":"437_CR63","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12951-021-00861-0","volume":"19","author":"R Bagherifar","year":"2021","unstructured":"Bagherifar R, et al. Nanoparticle-mediated synergistic chemoimmunotherapy for tailoring cancer therapy: recent advances and perspectives. J Nanobiotechnol. 2021;19(1):110.","journal-title":"J Nanobiotechnol"},{"issue":"2","key":"437_CR64","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ccell.2021.12.009","volume":"40","author":"E Limagne","year":"2022","unstructured":"Limagne E, et al. MEK Inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells. Cancer Cell. 2022;40(2):136\u2013e15212.","journal-title":"Cancer Cell"},{"issue":"3","key":"437_CR65","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41571-018-0142-8","volume":"16","author":"JS O\u2019Donnell","year":"2019","unstructured":"O\u2019Donnell JS, Teng MWL, Smyth MJ. Cancer immunoediting and resistance to T cell-based immunotherapy. Nat Rev Clin Oncol. 2019;16(3):151\u201367.","journal-title":"Nat Rev Clin Oncol"},{"key":"437_CR66","doi-asserted-by":"publisher","first-page":"799428","DOI":"10.3389\/fimmu.2021.799428","volume":"12","author":"M Xiao","year":"2021","unstructured":"Xiao M, et al. Tumor-Associated macrophages: critical players in drug resistance of breast Cancer. Front Immunol. 2021;12:799428.","journal-title":"Front Immunol"},{"key":"437_CR67","doi-asserted-by":"publisher","first-page":"643771","DOI":"10.3389\/fimmu.2021.643771","volume":"12","author":"AK Mehta","year":"2021","unstructured":"Mehta AK, et al. Macrophage biology and mechanisms of immune suppression in breast Cancer. Front Immunol. 2021;12:643771.","journal-title":"Front Immunol"},{"issue":"10","key":"437_CR68","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/j.cell.2022.03.033","volume":"185","author":"P Baldominos","year":"2022","unstructured":"Baldominos P, et al. Quiescent cancer cells resist T cell attack by forming an immunosuppressive niche. Cell. 2022;185(10):1694\u2013e170819.","journal-title":"Cell"},{"issue":"6","key":"437_CR69","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.fertnstert.2018.05.006","volume":"109","author":"LH Goetz","year":"2018","unstructured":"Goetz LH, Schork NJ. Personalized medicine: motivation, challenges, and progress. Fertil Steril. 2018;109(6):952\u201363.","journal-title":"Fertil Steril"},{"issue":"Suppl 2","key":"437_CR70","first-page":"S90","volume":"62","author":"SM Sisodiya","year":"2021","unstructured":"Sisodiya SM. Precision medicine and therapies of the future. Epilepsia. 2021;62(Suppl 2):S90\u2013105.","journal-title":"Epilepsia"},{"issue":"10","key":"437_CR71","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1016\/j.cmet.2021.09.002","volume":"33","author":"SM Morrissey","year":"2021","unstructured":"Morrissey, S.M., et al., Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming. Cell Metab. 2021;33(10):2040\u20132058 e10.","journal-title":"Cell Metab"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00437-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-025-00437-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00437-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T13:06:57Z","timestamp":1747228017000},"score":1,"resource":{"primary":{"URL":"https:\/\/hereditasjournal.biomedcentral.com\/articles\/10.1186\/s41065-025-00437-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,11]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["437"],"URL":"https:\/\/doi.org\/10.1186\/s41065-025-00437-0","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,11]]},"assertion":[{"value":"27 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Is not applicable for this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"74"}}